Podcasts about bronchioloalveolar

 Updated September 2021 1 Presumptive Disability Benefits Whatis “Presumptive”Service Connection? VA presumesthat certain disabilities were caused bymilitary service. Thisis because of the unique circumstances of a specific Veteran's military service. If a presumed condition is diagnosed in a Veteran within a certain group, they can be awarded disability compensation. What are “Presumptive” Conditions? If you are diagnosed with a chronic disease within one year of active duty release, you should apply for disability compensation. Examples of chronic disease include: arthritis, diabetes or hypertension. Or, if you served continuously for atleast 90 days and are diagnosedwith amyotrophic lateralsclerosis (ALS) after discharge, you can establish service connection for the disease. Veteransin the following groups may qualify for “presumptive” disability benefits: • Former prisoners of war who: • Have a condition thatis atleast 10 percent disabling • Depending on length of imprisonment, specific conditions are presumed  Imprisoned for any length of time: • Psychosis • Any of the anxiety states • Dysthymic disorder(or depressive neurosis) • Organic residuals of frostbite • Post- traumatic osteoarthritis • Heart disease or hypertensive vascular disease • Stroke and the residual effects • Osteoporosis, when the Veteran has posttraumatic stress disorder Updated September 2021 2  Imprisoned for at least 30 days: • Beriberi (including beriberi heart disease) • Chronic dysentery • Helminthiasis • Malnutrition (including optic atrophy) • Pellagra • Other nutritional deficiencies • Irritable bowel syndrome • Peptic ulcer disease • Peripheral neuropathy • Cirrhosis of the liver • Avitaminosis • Osteoporosis • Vietnam Veterans who were: • Exposed to AgentOrange • Served in the Republic of Vietnamor on a vessel operating not more than 12 nauticalmiles seaward from the demarcation line of the waters of Vietnam and Cambodia between Jan. 9, 1962 andMay 7, 1975 • Specific presumed conditions are: • AL amyloidosis • B-cell leukemia • Chronic lymphocytic leukemia • Multiple myeloma • Type 2 diabetes • Hodgkin's disease • Ischemic heart disease (including but notlimited to, coronary artery disease and atherosclerotic cardiovascular disease) • Non-Hodgkin's lymphoma • Parkinson's disease • Parkinsonism • Prostate cancer • Respiratory cancers • Soft-tissue sarcoma (not including osteosarcoma, chondrosarcoma, Kaposi'ssarcoma or mesothelioma) • Bladder cancer • Hypothyroidism Updated September 2021 3  The following conditions, if they become greater than 10 percent debilitating within a year of exposure to an herbicide agent: • Acute and subacute peripheral neuropathy • Chloracne or other similar acneform disease • Porphyria cutanea tarda • Atomic Veterans exposed to ionizing radiationand who experienced one of the following: • Participated in atmospheric nuclear testing • Occupied or were prisoners of warinHiroshima orNagasaki • Served before Feb. 1, 1992, at a diffusion plantin Paducah, Kentucky, Portsmouth, Ohio orOak Ridge, Tennessee • Served before Jan. 1, 1974, at Amchitka Island, Alaska Specific presumed conditions are:  All forms of leukemia, except chronic lymphocytic leukemia  Cancer of the thyroid, breast, pharynx, esophagus, stomach, small intestine, pancreas, bile ducts, gall bladder, salivary gland, urinary tract, brain, bone, lung, colon or ovary  Bronchioloalveolar carcinoma  Multiple myeloma  Lymphomas, other than Hodgkin's disease  Primary liver cancer, except if there are indications of cirrhosis or hepatitis B • Gulf War Veterans who: • Served in the Southwest Asia Theater of Operations • Have a condition that is at least 10 percent disabling by Dec. 31, 2026 • Specific presumed conditions are:  Medically unexplained chronic multi-symptom illnesses that exist for six months or more, such as: • Chronic fatigue syndrome • Fibromyalgia • Irritable bowel syndrome  Any diagnosed or undiagnosed illness that warrants a presumption of service connection, as determined by the Secretary of Veterans Affairs Updated September 2021 4 • Signs or symptoms of an undiagnosed illness include: • Fatigue • Skin symptoms • Headaches • Muscle pain • Joint pain • Neurological or neuropsychologicalsymptoms • Symptoms involving the upper or lower respiratory system • Sleep disturbance • Gastrointestinalsymptoms • Cardiovascular symptoms • Weight loss • Menstrual disorders • Gulf WarVeterans who: • Served in the Southwest Asia Theater of Operations orinAfghanistan on or after September 19, 2001  Manifest one of the following infectious diseasesto a degree of 10 percent ormore within 1 year of separation: • Brucellosis • Campylobacterjejuni • Coxiella burnetii (Q fever) • Nontyphoid Salmonella • Shigella • West Nile virus • Malaria (or when accepted treatisesindicate the incubation period began during a qualifying period of service)  Manifestto a degree of 10 percent ormore at any time after separation: • Mycobacteriumtuberculosis • Visceral leishmaniasis • Gulf War Deployed Veterans who: • Served any length of time in the Southwest Theater of Operations during the Persian Gulf War, or • Served any length of time in Afghanistan, Syria, Djibouti or Uzbekistan on or after September 19, 2001 and • Manifests one of the following to any degree within 10 years from the date of separation from military service: o Asthma o Rhinitis o Sinusitis, to include rhinosinusitis 

Bronchioloalveolar carcinoma (BAC) is an unusual subtype of lung cancer; medical oncologist Dr. Jack West reviews the evidence on the best systemic therapy to treat advanced, multifocal BAC.

Bronchioloalveolar carcinoma (BAC) is an unusual subtype of lung cancer; medical oncologist Dr. Jack West reviews the evidence on the best systemic therapy to treat advanced, multifocal BAC.

Bronchioloalveolar carcinoma (BAC) is an unusual subtype of lung cancer; medical oncologist Dr. Jack West reviews the evidence on the best systemic therapy to treat advanced, multifocal BAC.

Dr. Jack West, medical oncologist/lung cancer specialist, describes special management considerations for indolent lung cancers that may not require treatment or are at risk for "over-treatment."

Dr. Jack West, medical oncologist/lung cancer specialist, describes special management considerations for indolent lung cancers that may not require treatment or are at risk for "over-treatment."

Dr. Jack West, medical oncologist/lung cancer specialist, describes special management considerations for indolent lung cancers that may not require treatment or are at risk for "over-treatment."

Unfortunately, there is as much misinformation as good information about the unusual subtupe of lung cancer known as bronchioloalveolar carcinoma (BAC) or adenocarcinoma in situ. Dr. Jack West reviews the top 5 myths.

Unfortunately, there is as much misinformation as good information about the unusual subtupe of lung cancer known as bronchioloalveolar carcinoma (BAC) or adenocarcinoma in situ. Dr. Jack West reviews the top 5 myths.

Unfortunately, there is as much misinformation as good information about the unusual subtupe of lung cancer known as bronchioloalveolar carcinoma (BAC) or adenocarcinoma in situ. Dr. Jack West reviews the top 5 myths.

Bronchioloalveolar carcinoma (BAC), also known as adenocarcinoma in situ, is an unusual subtype of lung cancer with its own appearance under a microscope and on imaging. Dr. Jack West introduces some of the basics of the unique features of BAC.

Bronchioloalveolar carcinoma (BAC), also known as adenocarcinoma in situ, is an unusual subtype of lung cancer with its own appearance under a microscope and on imaging. Dr. Jack West introduces some of the basics of the unique features of BAC.

Bronchioloalveolar carcinoma (BAC), also known as adenocarcinoma in situ, is an unusual subtype of lung cancer with its own appearance under a microscope and on imaging. Dr. Jack West introduces some of the basics of the unique features of BAC.

Dr. Jack West reviews what situations would make a "local" treatment like radiation appropriate in a situation where a patient has known advanced/metastatic lung cancer. 

Case discussion of management options for an elderly man with slowly progressing BAC, with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute.

Case discussion of management options for an elderly man with slowly progressing BAC, with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute.

Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the neuroendocrine spectrum of lung tumors and the evolving views on bronchioloalveolar carcinoma (BAC).

Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the neuroendocrine spectrum of lung tumors and the evolving views on bronchioloalveolar carcinoma (BAC).

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West presents a general background on the distinct demographic, pathologic, molecular, and treatment outcome features seen among never-smokers with lung cancer.

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the development of current standards and anticipated benefits vs. risks of second line chemotherapy for advanced non-small cell lung cancer (NSCLC).

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the unique clinical, imaging, and treatment response features of advanced bronchioloalveolar carcinoma (BAC), a distinct sybtype of lung adenocarcinoma.